Literature DB >> 26838368

[Immune response to Mycobacterium tuberculosis].

A Nowag1, P Hartmann2,3.   

Abstract

Infections with Mycobacterium tuberculosis (MTB) induce complex immune responses involving an orchestrated interplay of innate and adaptive immune mechanisms. Why the immune system fails to eradicate the pathogen and at best achieves control of infection in the latent stage, still remains an unsolved mystery even more than 100 years after the discovery of MTB by Robert Koch. This article provides an overview of the current state of the art in the constantly evolving field of tuberculosis (TB) immunology. This review focuses on a change of paradigm proposing that in the latent stage MTB is anything but dormant and that latent TB is not merely a state of bacterial stasis but a state of dynamic bacterial and immunological equilibrium. The understanding of these dynamics is crucial for the development of new drugs against MTB as well as vaccines that aim to provide effective protection against the disease.

Entities:  

Keywords:  Cytokines; Immunity, adaptive; Immunity, innate; Latent tuberculosis; Tumor necrosis factor alpha

Mesh:

Year:  2016        PMID: 26838368     DOI: 10.1007/s00108-015-0016-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  67 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis.

Authors:  JoAnn M Tufariello; Kaixia Mi; Jiayong Xu; Yukari C Manabe; Anup K Kesavan; Joshua Drumm; Kathryn Tanaka; William R Jacobs; John Chan
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice.

Authors:  H Kaneko; H Yamada; S Mizuno; T Udagawa; Y Kazumi; K Sekikawa; I Sugawara
Journal:  Lab Invest       Date:  1999-04       Impact factor: 5.662

4.  Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice.

Authors:  Daniel L Barber; Katrin D Mayer-Barber; Lis R V Antonelli; Mark S Wilson; Sandra White; Patricia Caspar; Sara Hieny; Irini Sereti; Alan Sher
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

Review 5.  Initiation and regulation of T-cell responses in tuberculosis.

Authors:  K B Urdahl; S Shafiani; J D Ernst
Journal:  Mucosal Immunol       Date:  2011-03-30       Impact factor: 7.313

6.  Lung neutrophils facilitate activation of naive antigen-specific CD4+ T cells during Mycobacterium tuberculosis infection.

Authors:  Robert Blomgran; Joel D Ernst
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

Review 7.  Role of innate cytokines in mycobacterial infection.

Authors:  A M Cooper; K D Mayer-Barber; A Sher
Journal:  Mucosal Immunol       Date:  2011-03-23       Impact factor: 7.313

Review 8.  Letting sleeping dos lie: does dormancy play a role in tuberculosis?

Authors:  Michael C Chao; Eric J Rubin
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

9.  Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2.

Authors:  Niaz Banaiee; Eleanor Z Kincaid; Ulrike Buchwald; William R Jacobs; Joel D Ernst
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

10.  A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion.

Authors:  Sandra M Newton; Rebecca J Smith; Katalin A Wilkinson; Mark P Nicol; Natalie J Garton; Karl J Staples; Graham R Stewart; John R Wain; Adrian R Martineau; Sarah Fandrich; Timothy Smallie; Brian Foxwell; Ahmed Al-Obaidi; Jamila Shafi; Kumar Rajakumar; Beate Kampmann; Peter W Andrew; Loems Ziegler-Heitbrock; Michael R Barer; Robert J Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-06       Impact factor: 11.205

View more
  1 in total

Review 1.  [Nontuberculous mycobacterial infections].

Authors:  A Nowag; M Platten; G Plum; P Hartmann
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.